Skip to main content

Schedule M series - Training

Training:

Training is one of the important aspect in pharmaceutical industry. 

Training are broadly categories as below:

1. Induction training 

2. SOP training 

3. On-job training and

4. Training on Regularly & other soft skills.

Training is covered in all the cGMP guidance and auditors verify the person involved in manufacturing of drug product are well trained to execute his/her task.

Schedule M also emphasized the importance of training hence, covered the following requirement on training.

1.1: Beside basic training on the theory and practice of GMP, newly appointed personal shall receive training to the duties assigned to them.

1.2: Company should provide training in accordance with a written training program for all personal whose duties take them into manufacturing area or QC. This training includes all the personal from the technical, maintenance and cleaning (house keeping) and for other personnel as required.

1.3: Continues training shall the provided and effectiveness of the training shall be assessed on periodic basis. Training record shall be kept.

1.4: Specific training shall be delivered to the personal working in area where contamination is a hazard.

1.5: Preferably Visitors and untrained personnel shall not allow to be taken into production and quality control areas.

If unavoidable, they shall be given relevant information in advance and the prescribed protective clothing.

1.6: The contract staff and consultant shall be qualified for the services they provide. Evidence of this shall be included in training records.

Comments

Popular posts from this blog

Hold Time study for Pharmaceutical products

Introduction: Manufacture should ensure that the products they are manufacture are safe, effective and quality required for intended use. System should be in-place and in-use to ensure that the products manufactured as per validated process. As per Good manufacturing practices, manufacture should ensure that the dispensing raw materials and packing materials, intermediates products, bulk and finished product are stored under suitable conditions. Storage arrangement should be such which safeguard the subsequent processing, stability, safety, efficacy or quality of starting materials, intermediate products, and bulk drug prior to final packing. Maximum hold time should be established to ensure that intermediate and bulk product can be held without producing results outside the acceptance criteria for the quality of the material. Intermediate and bulk product should not be store beyond the established hold time. The choice of maximum hold time should be supported by relevant data. man...

Good Laboratory practices and Requirements of Premises and Equipment's.

Good Laboratory Practices and Requirement of premises and Equipment's General Requirements:- a) The laboratory or the the organization of which it is a part must be an entity that is legally authorized to function and can be held legally responsible. b) Management ensures that the laboratory carry out its testing, calibration, validation, and all other technical activities in such a way as to meet Good Laboratory Practices (GLP) requirements.  c) The Quality manger shall prepare a schedule for technical audit of the laboratory for GLP compliance by an expert or experts appointed by the top-management other than the in-charge of the laboratory and shall ensures the maintenance of documented quality systems as per quality manual. Premises:- a) The laboratory shall be designed, constructed and maintained so as to prevent entry of insects and rodents besides cross contamination. b) Wall, floor and ceilings ( interior surface) shall be smooth and free from cracks and permits easy cleani...

Revised schedule M 2023.

 Dear friend's Hope all of you are doing well....! Schedule M has been received and notified on 28th December 2023. There are many changes as compare to previous version. The revised schedule M is divided into thirteen parts. In coming days I will provide the summary of these changes in this site for your easy reference. This change impacts all the pharmaceutical manufacturing plants in India. See you...